(1) Whether, with reference to his reply to question 1123 on 4 May 2010, the regulations to guide the registration of complementary medicines have been finalised; if not, (a) why not, (b) when will it be finalised and (c) what are the reasons for the delay; if so, (i) when were the regulations finalised, (ii) when will the call for registration be made and (iii) what was the cost of developing the regulations; (2) (a) which complementary medicines are not covered by the Medicines and Substances Control Act, Act 10 of 1965 and (b) why was it necessary to formulate new regulations?